The PHQ-9 and the PHQ-2 are useful instruments to detect major depressive disorder in primary care, provided a high score is followed by an additional diagnostic work-up. The scores on the questionnaire range from 0 to 27: a score of 10 or higher is indicative of moderate or severe depression and is used to consider major depressive disorder present. In conclusion, the results presented here indicate that the PHQ-9 and the PHQ-2 are useful instruments to detect major depressive disorder in primary care.

Major depression is diagnosed if 5 or more of the 9 depressive symptom criteria have been present at least “more than half the days” in the past 2 weeks, and 1 of the symptoms is depressed mood or anhedonia. One of the nine symptom criteria (“thoughts that you would be better off dead or of hurting yourself in some way”) counts if present at all, regardless of duration. The PHQ-9 can be used to make criteria-based diagnoses of depressive disorders and to grade depressive symptom severity.

The PHQ-9 is thus a dual-purpose instrument that, with the same nine items, can establish provisional depressive disorder diagnoses as well as grade depressive symptom severity. Major depression is diagnosed if five or more of the nine depressive symptom criteria have been present at least “more than half the days” in the past 2 weeks, and one of the symptoms is depressed mood or anhedonia. One of the nine symptom criteria (“thoughts that you would be better off dead or of hurting yourself in some way”) counts if present at all, regardless of duration.

The PHQ-9 incorporates DSM-IV depression diagnostic criteria with other leading major depressive symptoms into a brief self-report tool. The 9 items of the PHQ-9 are based directly on the nine diagnostic criteria for major depressive disorder in the DSM-IV. Suggested treatment actions based on PHQ-9 score: 15 – 19 (Major depression, moderately severe): Antidepressant or psychotherapy; ≥20 (Major Depression, severe): Antidepressant and psychotherapy (especially if not improved on monotherapy).

Major depressive disorder (MDD) is suggested if: • Of the 9 items, 5 or more are checked as at least ‘more than half the days’ • Either item 1 or 2 is checked as at least ‘more than half the days’. Other depressive syndrome is suggested if: [criteria follow]. The PHQ-9 score can be used to monitor severity over time and response to treatment.

In addition to making criteria-based diagnosis of depression, the PHQ-9 can also be used as a measure of depression severity to monitor treatment progress and guide clinicians' treatment decisions. ... The PHQ-9 score not only aids in making the depression diagnosis but also in selecting and monitoring treatment.

The authors concluded that the Patient Health Questionnaire (PHQ-9) is a valid method for diagnosing major depressive episodes (MDEs) in subgroups of primary care patients with a high prevalence of MDEs. The PHQ-9 is a useful diagnostic tool when applied in selected primary care populations with a high prevalence of depressive disorder. Practice: The authors stated that the PHQ-9 is a valid instrument to detect patients with MDEs.

Unlike other depression scales, PHQ-9 includes 9 items which focus on the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) for MDD. The PHQ-9 is a brief self-report scale that assesses the presence and severity of depressive symptoms according to DSM criteria and is widely used in clinical practice to monitor treatment outcomes.

The PHQ 2 is a tool used to screen for depression, while the PHQ 9 tool is used to screen or diagnose depression, measure the severity of symptoms, and measure a patient’s response to treatment. ... PHQ–9 Score / Depression Severity / Proposed Treatment Actions 0–4 None–Minimal – None 5–9 Mild – Watchful waiting; repeat PHQ 9 at follow–up 10–14 Moderate – Treatment plan, consider counseling, follow up and/or pharmacotherapy 15–19 Moderately Severe – Active treatment with pharmacotherapy and/or psychotherapy 20–27 Severe – Immediate initiation of pharmacotherapy and, if severe impairment or poor response to therapy, expedited referral to a mental health specialist for psychotherapy and/or collaborative management. ... PHQ–9 Score at 4–6 weeks / Treatment Response / Treatment Plan (e.g., drop of 5 points from baseline: adequate – no treatment change needed; drop of 1 point: inadequate – increase dose, augmentation, consultation, add psychotherapy).

PHQ-9 showed good reliability and validity, and high adaptability for patients with MDD in psychiatric hospital. PHQ-9 is a rapid and effective tool for detection as well as for monitoring the severity of depression. The PHQ-9 was used as a self-administered, screening tool for assessment of the severity of depressive symptoms.

Table 3. PHQ-9 score, severity/provisional diagnosis, and treatment recommendations: <5 – Minimal symptoms – No active treatment; re-evaluate. 5–9 – Mild symptoms – Watchful waiting, self-management education, periodic rescreening. 10–14 – Major depression, mild – Pharmacotherapy or psychotherapy, creation of a treatment and follow-up plan, education, reevaluation. 15–19 – Major depression, moderately severe – Immediate institution of treatment (pharmacotherapy and/or psychotherapy). ≥20 – Major depression, severe – Immediate institution of treatment, often combined and more intensive, and consideration of referral.

Background: The PHQ-9 is widely used in primary care to monitor depression outcomes, but evidence is limited regarding how PHQ-9 scores should be used to guide treatment decisions. ... We developed and tested a treatment decision rule based on changes in PHQ-9 scores at 4–6 weeks. ... Patients with a PHQ-9 score decrease of ≥5 points were considered to have an adequate response and did not require treatment change. Patients with a decrease of 2–4 points had a possibly inadequate response and may warrant an increase in antidepressant dose or therapy intensity. Patients with a decrease of ≤1 point had an inadequate response and were recommended for treatment intensification. ... Use of these PHQ-9-based rules improved depression outcomes compared with usual care.

The items in the newly revised Patient Health Questionnaire-9 (PHQ-9) were designed to correspond with the criteria for major depressive episode given in the Diagnostic and Statistical Manual of Mental Disorders, 4th ed. The PHQ-9 is an excellent questionnaire for confirming the diagnosis of major depressive episode. A score of 10 points or higher indicates the presence of major depressive episode. Serial or sequential screening for depression with the PHQ-2 followed by the PHQ-9 has been shown to be effective in identifying patients with depression in a primary care setting.

The PHQ-9 consists of nine items, each corresponding to one of the nine DSM-5 criteria for MDD. It aligns with the diagnostic criteria for depression in the DSM-5 and is used in primary care, mental health, and research settings to identify and monitor depression over time. A score of ≥10 is considered a sensitive and specific cut-off for major depressive disorder. Score interpretation can guide clinical decisions, with higher scores indicating need for more intensive treatment or referral.

The Severity Measure for Depression—Adult (adapted from the Patient Health Questionnaire–9 [PHQ-9]) is a self-rated 9-item measure that assesses the severity of depressive symptoms in individuals age 18 and older. They should be used in research and evaluation as potentially useful tools to enhance clinical decision-making and not as the sole basis for making a clinical diagnosis. Clinicians are encouraged to use their clinical judgment in addition to the information provided by these measures.

The Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report tool used to screen, diagnose, monitor, and measure the severity of depression. Total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively. PHQ-9 Score and Proposed Treatment Actions: 0–4 None-minimal – None; 5–9 Mild – Watchful waiting; repeat PHQ-9 at follow-up; 10–14 Moderate – Treatment plan, considering counseling, follow-up and/or pharmacotherapy; 15–19 Moderately Severe – Active treatment with pharmacotherapy and/or psychotherapy; 20–27 Severe – Immediate initiation of pharmacotherapy and, if severe impairment or poor response to therapy, expedited referral to a mental health specialist.

The PHQ-9 is the most widely used measure for depression in primary care settings and is an effective tool for monitoring outcome over time and guiding treatment adjustments. ... Clinicians often use PHQ-9 scores to decide whether to initiate or modify treatment, such as increasing the dose of antidepressants, adding psychotherapy, or referring to specialty care, based on changes in scores and residual symptom burden. ... It assesses the 9 DSM-IV criteria for major depression and can thus be used to identify probable major depressive disorder and track symptom change.

The PHQ-9 measures depression severity based on the nine DSM-5 diagnostic criteria for major depressive disorder. The nine DSM-5 criteria assessed are: anhedonia, depressed mood, sleep disturbances, fatigue or loss of energy, appetite changes, feelings of worthlessness or excessive guilt, diminished ability to concentrate, psychomotor agitation or retardation, and recurrent thoughts of death or suicidal ideation. Provisional diagnosis of major depressive disorder requires 5 or more items scored as 2 or 3, including item 1 or 2, and item 9 counts if present at any frequency.

The PHQ-9 is the depression module, which scores each of the nine diagnostic criteria for major depression in Diagnostic and Statistical Manual Fourth Edition as ‘0’ (not at all) to ‘3’ (nearly every day). At an initial visit the PHQ-9 can be used to assist with diagnosis and identification of problem symptoms. At the follow-up visit, the PHQ-9 is used to measure treatment response and identify specific symptoms that are not responding. Thus the questionnaire is a useful tool to assist clinicians in diagnosing depression and monitoring the response to treatment.

The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual (DSM) and asks about symptoms in the previous two weeks. Each of its nine items corresponds to one of the symptoms of major depression, and it allows for a severity score to aid in clinical decision-making. The PHQ-9 was created to provide a quick, reliable method for evaluating the presence and severity of depressive symptoms based on the criteria outlined in the DSM.

If a patient answers “yes” to one or both questions on the PHQ-2, the PHQ-9 patient health questionnaire is recommended to further assess the patient’s risk for depression. The PHQ-9 screener can be used to determine the severity of depression, which helps determine next steps for treatment. ... A score of 5–9 on the PHQ-9 signifies that the patient is experiencing mild depression. Consider follow up with the patient in 2–3 weeks without prescribing any medication. Consider referral to a behavioral health provider for talk therapy, especially if the patient is expressing suicidal ideation. A score of 10–19 signifies that the patient is experiencing moderate to moderately severe depression. ... Through the first year following a depression diagnosis, regular follow-up visits and use of the PHQ-9 at least once a month are recommended until the patient’s symptoms have improved for a period of one year.

This concise nine-item health questionnaire can function as a screening tool, aids in diagnosis, and measures treatment response. At the initial visit, the PHQ-9 aids in the diagnosis and identification of potential depressive symptoms. At the follow-up visit, the PHQ-9 can be used to measure treatment response and identify specific symptoms that are not responding. Elevated scores strongly correlate with a major depression diagnosis. However, it’s essential to remember that not everyone with a high PHQ-9 score will have major depression. Trained clinicians must make the final diagnosis.

The Personal Health Questionnaire (PHQ-9) Score Interpretation and Actions guide links scores to treatment decisions for initial assessment and ongoing monitoring. For example, a total score of 1–4 suggests the patient may not need depression treatment; quarterly monitoring is suggested if there is a history of previous bouts of depression or strong family history. Ongoing Monitoring: A 5-point reduction in score or greater indicates a solid response to treatment… Lack of response within 8 weeks may require medication change, additional medication or augmentation or referral to a psychiatrist. Ongoing Monitoring: Indicates severe depression that would require psychiatric referral for consultation and/or management.

Each of the nine items reflects a DSM-5 symptom of depression. The PHQ-9 questions reflect the diagnostic criteria for major depressive disorder (MDD) found in the DSM-5. Questions are about interest/pleasure (anhedonia), feeling down or depressed, sleep problems, low energy, appetite changes, feelings of failure or low self-worth, concentration difficulties, psychomotor changes, and thoughts of suicide.

Using PHQ-9 Diagnosis and Score for Initial Treatment: The PHQ-9 incorporates DSM-IV depression diagnostic criteria into a brief survey. Total score severity ranges are linked to recommended treatment options such as watchful waiting, counseling, antidepressant medication, and combination therapy. Treatment planning can be guided by both the categorical diagnosis (major depressive disorder vs. other depressive syndrome) and the numerical severity score.

Symptoms of depression are commonly known by the SIGECAPS mnemonic: sleep disorders; interest deficit (anhedonia); guilt; energy deficit; concentration deficit; appetite disorder; psychomotor retardation or agitation; and suicidality. Depressed mood and anhedonia are the two cardinal symptoms of depression. The presence of four SIGECAPS symptoms plus depressed mood or anhedonia suggests depression, and further screening should be considered. These symptoms correspond closely to those assessed in tools such as the PHQ-9.

The Patient Health Questionnaire (PHQ-9) is a widely used instrument for diagnosing depression and assessing severity. The study evaluated the optimal cut-off score for diagnosing depression with the PHQ-9 against a structured clinical interview. It concluded that cut-off scores around 10 provide the best balance between sensitivity and specificity for major depressive disorder, supporting the use of PHQ-9 both for case-finding and severity assessment in clinical practice.

The PHQ-9 is a quick, evidence-based depression screening tool that helps therapists assess symptom severity and monitor progress over time. ... Therapists can use PHQ-9 results to guide treatment planning, determine appropriate levels of care, and track changes in depressive symptoms throughout therapy. ... While the PHQ-9 is highly reliable and easy to administer, it should be used alongside clinical interviews and other assessment tools rather than as a standalone diagnosis.

Major Depression Episode DSM-5 criteria require five or more symptoms in a 2‑week period, with at least one being depressed mood or loss of interest or pleasure. The listed symptoms include depressed mood, diminished interest or pleasure, appetite or weight changes, sleep disturbance, psychomotor agitation or retardation, fatigue, feelings of worthlessness or excessive guilt, diminished ability to think or concentrate, and recurrent thoughts of death or suicidal ideation. These core criteria form the basis for instruments like the PHQ-9 that operationalize DSM symptoms into a questionnaire format.

It is a standardized rating scale that helps quantify symptom severity during the assessment step of a depression treatment plan. ... Step one: administer the PHQ-9 at intake to set a baseline. Capture the score before treatment starts so you have a reference point to measure every later change against. ... Step three: tie the score to a measurable, time-bound objective in the plan. ... Step four: re-administer at intervals and document the result against the objective. Re-administer the PHQ-9 at regular intervals so you can see the trend, not just a single point in time.

The Patient Health Questionnaire (PHQ-9) is a self-administered diagnostic screening and severity tool for depression. Each item is evaluated on a severity scale ranging from 0 to 3 where the respondent is asked to rate how often each symptom occurred over the last 2 weeks (0-not at all; 1-several days; 2-more than half of the days or 3-nearly every day), yielding a total score ranging from 0–27. Score interpretation: 1–4 minimal depression, 5–9 mild depression, with increasing scores reflecting more severe depressive symptoms. The PHQ-9 can be used to monitor depressive symptoms over time.

Mastering Patient Health Questionnaire 9 Interpretation explains that the PHQ-9 is based on the nine criteria for major depressive episode and is commonly used in primary care to assess depression severity and guide treatment decisions. Total Score and Depression Severity: Minimal Depression – No action is typically needed; Mild Depression – Use clinical judgment, often "watchful waiting" with repeat PHQ-9 at follow-up; Moderate Depression – Consider a treatment plan such as counselling, more frequent follow-ups, or pharmacotherapy; Moderately Severe Depression – Active treatment is strongly recommended, usually involving pharmacotherapy and/or psychotherapy.

The PHQ-9 (Patient Health Questionnaire-9) Calculator provides a scoring tool where each of the 9 items corresponds to DSM criteria for major depressive disorder and is scored from 0 to 3. The calculator categorizes total scores into none/minimal, mild, moderate, moderately severe, and severe depression, and notes that the PHQ-9 is used for initial screening as well as for tracking symptom severity over time to inform treatment planning and adjustment.

The Patient Health Questionnaire-9 (PHQ-9) is described as a brief tool that assesses the presence and severity of depressive symptoms over the past two weeks. Items correspond to the core DSM criteria for major depressive disorder such as depressed mood, anhedonia, sleep disturbance, fatigue, appetite changes, feelings of worthlessness or guilt, concentration difficulties, psychomotor changes, and suicidal ideation. It is commonly used in clinical practice to support diagnosis, evaluate baseline severity, and monitor changes in symptoms in response to treatment.